SCHEMBL8219412

SCHEMBL8219412

O=C1NC(=O)/C(=C\c2ccccc2F)N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ IGF1R P08069 1/20 0.53
▸ NPC1 O15118 2/20 0.51
▸ GSK3B P49841 3/20 0.51
▸ GAA P10253 3/20 0.50
▸ IKBKB O14920 1/20 0.49
▸ RAF1 P04049 1/20 0.49
▸ RPS6KB1 P23443 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ AKT1 P31749 1/20 0.49
▸ AKT2 P31751 1/20 0.49
▸ KDR P35968 1/20 0.49
▸ PRKAG1 P54619 1/20 0.49
▸ MAP2K1 Q02750 1/20 0.49
▸ PRKAA1 Q13131 1/20 0.49
▸ MAPK14 Q16539 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8219410 1.00 MAPT (0.53) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL8219415 1.00 MAPT (0.53) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL16543012 0.84 NPC1 (0.66) MAPTMEN1KMT2AALDH1A1IGF1R
SCHEMBL10749179 0.79 MEN1 (0.57) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL7690121 0.79 GAA (0.59) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL15421542 0.79 MEN1 (0.57) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL10749176 0.79 MEN1 (0.57) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL7690119 0.79 GAA (0.59) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL11134601 0.79 GSK3B (0.54) MAPTMEN1KMT2ASMN1; SMN2NPC1
SCHEMBL3467241 0.76 MEN1 (0.72) MAPTMEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188130-B1 Anti-cancer hydantoin compounds and methods UNIVERSITY OF LOUISIANA AT MONROE (US) 2012-05-29 — — US claimed
US-8188130-B1 Anti-cancer hydantoin compounds and methods UNIVERSITY OF LOUISIANA AT MONROE (US) 2012-05-29 — — US disclosed
Send feedback